Medical News Today: Existing drug may treat triple-negative breast cancer
Researchers have discovered that the drug estradiol may work as a new treatment for a type of triple-negative breast cancer, which is highly aggressive. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 9, 2018 Category: Consumer Health News Tags: Breast Cancer Source Type: news

Mayo researchers ID potential new treatment for one type of triple-negative breast cancer
(Mayo Clinic) Mayo Clinic researchers have identified the drug estradiol as a potential new treatment for a subset of women with triple-negative breast cancer. Their findings are published in the Proceedings of the National Academy of Sciences of the United States of America. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 4, 2018 Category: Cancer & Oncology Source Type: news

Medical News Today: What is an estradiol test and why is it used?
Estradiol is a form of the hormone estrogen, which plays a role in many aspects of growth and development. Doctors can measure estradiol levels with a blood test and may request one if they suspect any problems with sexual development or fertility. Learn more about the test's uses here, and what the results may mean. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 26, 2018 Category: Consumer Health News Tags: Endocrinology Source Type: news

Estradiol, Progesterone and CVD Risk in Postmenopausal Women Estradiol, Progesterone and CVD Risk in Postmenopausal Women
How might treatment with these hormones impact lipid parameters in postmenopausal women?Journal of the Endocrine Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 17, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Annovera (Segesterone Acetate and Ethinyl Estradiol Vaginal System) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 16, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Clears First Vaginal Ring for 1 Year of Birth Control FDA Clears First Vaginal Ring for 1 Year of Birth Control
Annovera (segesterone acetate and ethinyl estradiol vaginal system) is the first vaginal ring contraceptive approved that provides a full year of protection against unintended pregnancy.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 10, 2018 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Alert Source Type: news

FDA Approves Annovera (segesterone acetate and ethinyl estradiol) Vaginal Contraceptive System
NEW YORK, Aug. 10, 2018 /PRNewswire/ -- The Population Council, a global nonprofit research organization, announced it has received U.S. Food and Drug Administration (FDA) approval for Annovera ™ (segesterone acetate and ethinyl estradiol vaginal... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 10, 2018 Category: Drugs & Pharmacology Source Type: news

FDA approves new vaginal ring for one year of birth control
FDA approved Annovera (segesterone acetate and ethinyl estradiol vaginal system), a combined hormonal contraceptive for women of reproductive age used to prevent pregnancy and is the first vaginal ring contraceptive that can be used for an entire year. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 10, 2018 Category: American Health Source Type: news

A moderate estradiol level enhances neutrophil number and activity in muscle after traumatic injury but strength recovery is accelerated - Le G, Novotny SA, Mader TL, Greising SM, Chan SSK, Kyba M, Lowe DA, Warren GL.
Estrogen has been shown to protect against skeletal muscle injury and a reduced inflammatory response has been suggested as a possible protective mechanism. There are, however, dissenting reports. Our objective was to conduct an unbiased, comprehensive stu... (Source: SafetyLit)
Source: SafetyLit - July 27, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Esclim (Estradiol Transdermal) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 26, 2018 Category: Drugs & Pharmacology Source Type: news

EstroGel (Estradiol Gel) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 20, 2018 Category: Drugs & Pharmacology Source Type: news

Estradiol to androstenedione ratios moderate the relationship between neurological injury severity and mortality risk after severe TBI - Ranganathan P, Kumar RG, Oh BM, Rakholia MV, Berga S, Wagner AK.
Early declines in gonadotropin production, despite elevated serum estradiol, among patients with severe traumatic brain injury (TBI) suggests amplified aromatization occurs post-injury. Our previous work identifies estradiol (E2) as a potent mortality mark... (Source: SafetyLit)
Source: SafetyLit - July 19, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Femcon Fe (Norethindrone and Ethinyl Estradiol Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 12, 2018 Category: Drugs & Pharmacology Source Type: news

Imvexxy (Estradiol Vaginal Inserts) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 27, 2018 Category: Drugs & Pharmacology Source Type: news

Norethindrone and Ethinyl Estradiol Tablets (New - Discontinuation)
Drug Shortage (Source: FDA Drug Shortages)
Source: FDA Drug Shortages - June 20, 2018 Category: Drugs & Pharmacology Source Type: news